Elsevier

The Lancet

Volume 390, Issue 10110, 25 November–1 December 2017, Pages 2343-2345
The Lancet

Correspondence
Pembrolizumab is effective for drug-resistant gestational trophoblastic neoplasia

https://doi.org/10.1016/S0140-6736(17)32894-5Get rights and content

References (14)

There are more references available in the full text version of this article.

Cited by (131)

View all citing articles on Scopus
View full text